Gammeo enables the monitoring of all property issues related to a health facility through a simple and intuitive web interface.... View Article
Author Archives for Adeline Chauvigné
A New member: Gammeo
9 May 2025Gammeo enables the monitoring of all property issues related to a health facility through a simple and intuitive web interface.... View Article
The attraction of CESTI IHU has been the establishment of a professorial position specifically for Pierre-Antoine Gourraud
Professor Pierre-Antoine Gourraud, a recognized specialist in the fields of immunology, genetics and bioinformatics, leaves his position of Associate Professor... View Article
The attraction of CESTI IHU has been the establishment of a professorial position specifically for Pierre-Antoine Gourraud
9 May 2025Professor Pierre-Antoine Gourraud, a recognized specialist in the fields of immunology, genetics and bioinformatics, leaves his position of Associate Professor... View Article
FIRM project was funded at the level of 15 million euros
FIRM project is aimed at the development of an industrial sector producing innovative radioisotopes for medical use. Coordinated by the... View Article
FIRM project was funded at the level of 15 million euros
9 May 2025FIRM project is aimed at the development of an industrial sector producing innovative radioisotopes for medical use. Coordinated by the... View Article
Valneva Reports Positive Phase II Results for its Clostridium Difficile Vaccine Candidate
Valneva SE, a leading pure-play vaccine company, announced today, positive Phase II results for its prophylactic vaccine candidate against Clostridium... View Article
Valneva Reports Positive Phase II Results for its Clostridium Difficile Vaccine Candidate
9 May 2025Valneva SE, a leading pure-play vaccine company, announced today, positive Phase II results for its prophylactic vaccine candidate against Clostridium... View Article
Three publications confirm the effectiveness of the FR104, Effimune’s leading molecule
Effimune announced , the publication in leading scientific journals of three different studies confirming the efficacy of FR104 in new... View Article
Three publications confirm the effectiveness of the FR104, Effimune’s leading molecule
9 May 2025Effimune announced , the publication in leading scientific journals of three different studies confirming the efficacy of FR104 in new... View Article
Keosys : positive results from Phase 3 NETTER-1 Study
Keosys announces positive results from Phase 3 NETTER-1 Study centralized and assessed by its Innovative Cloud based Clinical Trial Imaging... View Article
Keosys : positive results from Phase 3 NETTER-1 Study
9 May 2025Keosys announces positive results from Phase 3 NETTER-1 Study centralized and assessed by its Innovative Cloud based Clinical Trial Imaging... View Article
€5.8 million to start a new era in vaccine purification
The DiViNe initiative, a joint European collaboration of renowned experts, convinced the European Commission. Its main concept is “positive“ vaccines... View Article
€5.8 million to start a new era in vaccine purification
9 May 2025The DiViNe initiative, a joint European collaboration of renowned experts, convinced the European Commission. Its main concept is “positive“ vaccines... View Article
Recherche clinique : le CHU de Nantes et l’ICO reconnue par l’INCa
Avec l’obtention du label CLIP2 (Centres Labellisés INCa de Phase Précoce), le dynamisme de la recherche clinique du CHU de... View Article
Recherche clinique : le CHU de Nantes et l’ICO reconnue par l’INCa
9 May 2025Avec l’obtention du label CLIP2 (Centres Labellisés INCa de Phase Précoce), le dynamisme de la recherche clinique du CHU de... View Article
DigitalforLife: Digital enterprises, meet health challenges
On May 28th, at the Ecole des Mines de Nantes, the fourth Digital & Health day took place. It was... View Article
DigitalforLife: Digital enterprises, meet health challenges
9 May 2025On May 28th, at the Ecole des Mines de Nantes, the fourth Digital & Health day took place. It was... View Article
Hemarina, 1er prix du Concours des Technologies Médicales Innovantes
L’entreprise Hemarina, accompagnée par ID2Santé et membre d’Atlanpole Biotherapies, est lauréate du Concours TMI 2015 organisé par l’Alliance pour le... View Article
Hemarina, 1er prix du Concours des Technologies Médicales Innovantes
9 May 2025L’entreprise Hemarina, accompagnée par ID2Santé et membre d’Atlanpole Biotherapies, est lauréate du Concours TMI 2015 organisé par l’Alliance pour le... View Article